Qtrly Results : Bajaj Finance, Ultratech Cement, HDFC BANK
You are here : Home / Quarterly Results / NATCO PHARMA LTD

NATCO PHARMA Quarterly Results Analysis Q2FY22 [Sep2021]

Q-o-Q REVENUES OPERATING PROFIT PROFIT AFTER TAX EPS Updated : 11-Nov-21 Details👇

NATCO PHARMA Quarterly Results

Consolidated Sep2021
UnAudited
Jun2021
UnAudited
Mar2021
UnAudited
Dec2020
UnAudited
Sep2020
UnAudited
Jun2020
UnAudited
Mar2020
UnAudited
Dec2019
UnAudited
Revenues ₹377 Cr ₹410 Cr ₹331 Cr ₹355 Cr ₹802 Cr ₹563 Cr ₹455 Cr ₹482 Cr
Expenses ₹307 Cr ₹301 Cr ₹255 Cr ₹273 Cr ₹526 Cr ₹392 Cr ₹327 Cr ₹354 Cr
Operating Income ₹71 Cr ₹110 Cr ₹76 Cr ₹83 Cr ₹276 Cr ₹171 Cr ₹128 Cr ₹129 Cr
Other Income ₹38 Cr ₹17 Cr ₹28 Cr ₹31 Cr ₹26 Cr ₹19 Cr ₹22 Cr ₹31 Cr
Interest ₹4 Cr ₹2 Cr ₹4 Cr ₹3 Cr ₹3 Cr ₹4 Cr ₹4 Cr ₹5 Cr
Depreciation ₹35 Cr ₹34 Cr ₹30 Cr ₹30 Cr ₹29 Cr ₹28 Cr ₹31 Cr ₹25 Cr
Profit Before Tax ₹70 Cr ₹91 Cr ₹71 Cr ₹80 Cr ₹271 Cr ₹158 Cr ₹117 Cr ₹129 Cr
Profit After Tax ₹65 Cr ₹75 Cr ₹53 Cr ₹63 Cr ₹204 Cr ₹122 Cr ₹93 Cr ₹104 Cr
EPS ₹3.57 ₹4.11 ₹2.90 ₹3.45 ₹11.12 ₹6.75 ₹5.17 ₹5.74

Check out Industry Peers

Peers & Returns1W1M1Y
NATCO PHARMA -0.4% 10.6% -0.4%
SUN PHARMACEUTICAL INDUSTRIES -4.7% 2.8% 38.8%
DIVIS LABORATORIES -6.2% -5.1% 20.4%
DR REDDYS LABORATORIES -2% -1.3% -11.4%
CIPLA -4.2% -0.8% 8.7%
GLAND PHARMA -2.5% -3% 55.2%
PIRAMAL ENTERPRISES -2.3% -0.4% 58.2%
CADILA HEALTHCARE -5.3% -10.4% -13.1%
TORRENT PHARMACEUTICALS 0.5% 4% 17.9%

NATCO PHARMA Quarterly Revenues

Revenues
Q-o-Q

-8.07 %

Y-o-Y

-52.98 %

Quarters Revenues % Change
Sep2021 ₹377 Cr
-8.07
Jun2021 ₹410 Cr
23.85
Mar2021 ₹331 Cr
-6.73
Dec2020 ₹355 Cr
-55.72
Sep2020 ₹802 Cr
42.39
Jun2020 ₹563 Cr
23.88
Mar2020 ₹455 Cr
-5.68
Dec2019 ₹482 Cr -

NATCO PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-35.79 %

Y-o-Y

-74.49 %

Quarters Operating Profit % Change
Sep2021 ₹71 Cr
-35.79
Jun2021 ₹110 Cr
44.09
Mar2021 ₹76 Cr
-7.64
Dec2020 ₹83 Cr
-70.15
Sep2020 ₹276 Cr
61.54
Jun2020 ₹171 Cr
33.36
Mar2020 ₹128 Cr
-0.31
Dec2019 ₹129 Cr -
Operating Margins
Q-o-Q

-30.16 %

Y-o-Y

-45.76 %

Quarters Operating Margin% % Change
Sep2021 18.69%
-30.16
Jun2021 26.76%
16.35
Mar2021 23%
-0.99
Dec2020 23.23%
-32.59
Sep2020 34.46%
13.47
Jun2020 30.37%
7.66
Mar2020 28.21%
5.70
Dec2019 26.69% -

NATCO PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-13.20 %

Y-o-Y

-68.07 %

Quarters Profit After Tax % Change
Sep2021 ₹65 Cr
-13.20
Jun2021 ₹75 Cr
41.51
Mar2021 ₹53 Cr
-16.40
Dec2020 ₹63 Cr
-68.91
Sep2020 ₹204 Cr
66.99
Jun2020 ₹122 Cr
31.01
Mar2020 ₹93 Cr
-10.73
Dec2019 ₹104 Cr -
PAT Margins
Q-o-Q

-5.58 %

Y-o-Y

-32.10 %

Quarters PAT Margin(%) % Change
Sep2021 17.26 %
-5.58
Jun2021 18.28 %
14.25
Mar2021 16 %
-10.36
Dec2020 17.85 %
-29.78
Sep2020 25.42 %
17.31
Jun2020 21.67 %
5.76
Mar2020 20.49 %
-5.36
Dec2019 21.65 % -

NATCO PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-13.14 %

Y-o-Y

-67.90 %

Quarters EPS % Change
Sep2021 ₹3.57
-13.14
Jun2021 ₹4.11
41.72
Mar2021 ₹2.9
-15.94
Dec2020 ₹3.45
-68.97
Sep2020 ₹11.12
64.74
Jun2020 ₹6.75
30.56
Mar2020 ₹5.17
-9.93
Dec2019 ₹5.74 -
STOCK RESEARCH & ANALYSIS Smart-Investing
LEARN VIA VIDEO COURSE Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

NATCO PHARMA related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP -1.4% 8% 47.6%
S&P BSE 400 MIDSMALLCAP -1.5% 8.2% 46.9%
S&P BSE 150 MIDCAP -1.7% 7% 42.5%
S&P BSE ALLCAP -2.2% 6.6% 28.6%
S&P BSE MID CAP -2.2% 5.9% 33%
S&P BSE 500 -2.3% 6.3% 27.2%
S&P BSE 250 LARGEMIDCAP -2.4% 6% 25.4%
S&P BSE LARGE MIDCAP -2.4% 6% 23.9%
S&P BSE 200 -2.4% 6.1% 24.7%
S&P BSE HEALTHCARE -4.3% 1% 11.2%
NSE Indices1W1M1Y
NIFTY MID SMALL400 -1.6% 7.7% 47.2%
NIFTY500 MULTICAP 50:25:25 -1.9% 7.1% 36.2%
NIFTY MIDCAP150 -2% 6.5% 41.6%
NIFTY FREE MIDCAP 100 -2.1% 7.2% 41.2%
NIFTY LARGE MIDCAP 250 -2.2% 6.1% 31.8%
NIFTY 500 -2.3% 6.2% 27.3%
NIFTY 200 -2.5% 6% 24.6%
NIFTY PHARMA -4.2% 1.3% 1.7%

You may also like the below Video Courses

Check out Intrinsic Value of Industry Peers
Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES LTD
Intrinsic Value of DIVIS LABORATORIES LTD
Intrinsic Value of DR REDDYS LABORATORIES LTD
Intrinsic Value of CIPLA LTD
Intrinsic Value of GLAND PHARMA LTD
Intrinsic Value of PIRAMAL ENTERPRISES LTD
Intrinsic Value of CADILA HEALTHCARE LTD
Intrinsic Value of TORRENT PHARMACEUTICALS LTD
Intrinsic Value of ALKEM LABORATORIES LTD
Intrinsic Value of LUPIN LTD
Intrinsic Value of AUROBINDO PHARMA LTD
Intrinsic Value of BIOCON LTD
Intrinsic Value of ABBOTT INDIA LTD
Intrinsic Value of LAURUS LABS LTD
Intrinsic Value of IPCA LABORATORIES LTD
Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of GLAND PHARMA LTD | BOM: 543245 | NSE: GLAND
Share Price & Financials of PIRAMAL ENTERPRISES LTD | BOM: 500302 | NSE: PEL
Share Price & Financials of CADILA HEALTHCARE LTD | BOM: 532321 | NSE: CADILAHC
Share Price & Financials of TORRENT PHARMACEUTICALS LTD | BOM: 500420 | NSE: TORNTPHARM
Share Price & Financials of ALKEM LABORATORIES LTD | BOM: 539523 | NSE: ALKEM
Share Price & Financials of LUPIN LTD | BOM: 500257 | NSE: LUPIN
Share Price & Financials of AUROBINDO PHARMA LTD | BOM: 524804 | NSE: AUROPHARMA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Share Price & Financials of ABBOTT INDIA LTD | BOM: 500488 | NSE: ABBOTINDIA
Share Price & Financials of LAURUS LABS LTD | BOM: 540222 | NSE: LAURUSLABS
Share Price & Financials of IPCA LABORATORIES LTD | BOM: 524494 | NSE: IPCALAB

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD
Market Cap of PIRAMAL ENTERPRISES LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of ALKEM LABORATORIES LTD
Market Cap of LUPIN LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of BIOCON LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of LAURUS LABS LTD
Market Cap of IPCA LABORATORIES LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z